Monnot Philippe

About Monnot Philippe

Philippe Monnot is a key governance figure at CROSSJECT, where he serves as Chairman of the Supervisory Board. His role is rooted in a long-standing relationship with the company: Gemmes Venture, the investment vehicle he co-founded in 1999, was CROSSJECT’s first shareholder. His position therefore reflects both his investor profile and his deep understanding of the governance and financing needs of innovative listed companies. As co-leader of Gemmes Venture, Monnot has helped build and support businesses across healthcare, digital services, fintech and cleantech. CROSSJECT states that Gemmes Venture was a founding shareholder in several healthcare ventures, including ASTEN SANTÉ, H2AD TELEHEALTH and VIVALIB. This track record points to a professional focus on venture and growth capital, entrepreneurial development, and the scaling of businesses operating in regulated and technology-driven sectors. Before his investment career, Philippe Monnot held senior positions in banking and financial advisory. According to CROSSJECT, he served as a member of the Executive Committee of Deutsche Bank in France, CEO of WORMS BANK and DETROYAT ASSOCIÉS, after earlier roles at STERN BANK and BANEXI. This background suggests substantial expertise in corporate finance, banking operations and strategic oversight, especially in companies requiring sophisticated funding and disciplined governance. At CROSSJECT, his responsibilities as Chairman of the Supervisory Board include overseeing strategic direction, ensuring proper balance between management and shareholders, and supporting the company through major operational and industrial milestones, including the development and validation of the ZENEO® needle-free platform. Recent corporate communications also show him participating in major governance announcements alongside executive management, underscoring his central role in the company’s institutional framework. An EM Lyon graduate, Philippe Monnot combines elite business education, senior banking experience and long-term involvement in venture-backed healthcare and industrial projects.